⌘K
S
SSI Strategy
Deals on record
1
Common Fundraising Type
Series A
A
Alesta Therapeutics
Biotechnology • Rare diseases
Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.
Deals on record
Common Fundraising Type
Biotechnology • Rare diseases
Alesta Therapeutics is a biotechnology company developing oral small molecule therapies for rare diseases.